An Ensemble Hybrid Feature Selection Method for Neuropsychiatric Disorder Classification

IEEE/ACM Trans Comput Biol Bioinform. 2022 May-Jun;19(3):1459-1471. doi: 10.1109/TCBB.2021.3053181. Epub 2022 Jun 3.

Abstract

Magnetic resonance imagings (MRIs) are providing increased access to neuropsychiatric disorders that can be made available for advanced data analysis. However, the single type of data limits the ability of psychiatrists to distinguish the subclasses of this disease. In this paper, we propose an ensemble hybrid features selection method for the neuropsychiatric disorder classification. The method consists of a 3D DenseNet and a XGBoost, which are used to select the image features from structural MRI images and the phenotypic feature from phenotypic records, respectively. The hybrid feature is composed of image features and phenotypic features. The proposed method is validated in the Consortium for Neuropsychiatric Phenomics (CNP) dataset, where samples are classified into one of the four classes (healthy controls (HC), attention deficit hyperactivity disorder (ADHD), bipolar disorder (BD), and schizophrenia (SD)). Experimental results show that the hybrid feature can improve the performance of classification methods. The best accuracy of binary and multi-class classification can reach 91.22 and 78.62 percent, respectively. We analyze the importance of phenotypic features and image features in different classification tasks. The importance of the structure MRI images is highlighted by incorporating phenotypic features with image features to generate hybrid features. We also visualize the features of three neuropsychiatric disorders and analyze their locations in the brain region.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Attention Deficit Disorder with Hyperactivity* / diagnostic imaging
  • Attention Deficit Disorder with Hyperactivity* / genetics
  • Brain / diagnostic imaging
  • Brain / pathology
  • Humans
  • Magnetic Resonance Imaging / methods
  • Schizophrenia* / diagnostic imaging
  • Schizophrenia* / genetics